1 Min Read
Oct 23 (Reuters) - COSMO PHARMACEUTICALS NV
* FDA GRANTS COSMO PHARMACEUTICALS BOTH QIDP AND FAST TRACK DESIGNATIONS FOR AEMCOLO Source text - bit.ly/2zvcXIc Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.